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Epithelial-to-mesenchymal 
transition may be a pathway 
to podocyte dysfunction and 
proteinuria
Podocyte dysfunction plays an essential role in the pathogene-
sis of proteinuria and glomerulosclerosis. However, the mech-
anism underlying podocyte dysfunction in many common 
forms of chronic kidney diseases remains poorly understood. 
Li et al. tested the hypothesis that podocytes may undergo 
epithelial-to-mesenchymal transition after injury. Condi-
tionally immortalized mouse podocytes were incubated with 
transforming growth factor-β1 (TGF-β1), a potent ﬁbrogenic 
cytokine that is upregulated in the diseased kidney. TGF-β1 
suppressed the slit diaphragm-associated protein P-cadherin 
(Figure), zonula occludens-1, and nephrin, a change consist-
ent with loss of the epithelial feature. Meanwhile, TGF-β1 
induced the expression of the intermediate ﬁlament protein 
desmin and the interstitial matrix components ﬁbronectin and 
collagen I. Furthermore, TGF-β1 promoted the expression 
and secretion of matrix metalloproteinase-9 by podocytes. 
Functionally, TGF-β1 increased albumin permeability across 
podocyte monolayers, as demonstrated by a paracellular albu-
min inﬂux assay. The expression of Snail, a key transcriptional 
factor that has been implicated in the initiation of epithe-
lial-to-mesenchymal transition, was induced by TGF-β1, and 
ectopic expression of Snail suppressed P-cadherin and nephrin 
in podocytes. In vivo, in addition to loss of nephrin and zonula 
occludens-1, mesenchymal markers such as desmin, ﬁbrob-
last-speciﬁc protein-1, and matrix metalloproteinase-9 could 
be observed in glomerular podocytes of diabetic nephropa-
thy. These results suggest that podocyte dediﬀerentiation and 
mesenchymal transition could be a potential pathway leading 
to their dysfunction, thereby playing a role in the genesis of 
proteinuria. (Am J Pathol 2008; 172: 299–308; doi:10.2353/
ajpath.2008.070057)
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Physiological role for uPAR 
signaling in the regulation of kidney 
permeability
Podocyte dysfunction, represented by foot process eﬀacement 
and proteinuria, is often the starting point for progressive kid-
ney disease. Therapies aimed at the cellular level of the disease 
are currently not available. The urokinase receptor (uPAR) is 
required for the development of podocyte foot process eﬀacement 
and proteinuria, which suggests that uPAR-inducible pathways 
are required for the remodeling of the ﬁltration barrier. Wei et 
al. showed that induction of uPAR signaling in podocytes led to 
foot process eﬀacement and urinary protein loss via a mechanism 
that includes lipid-dependent activation of αvβ3 integrin (Figure). 
Mice lacking uPAR (Plaur–/–) were protected from lipopolysac-
charide (LPS)-mediated proteinuria but developed disease after 
expression of a constitutively active β3 integrin. Gene transfer 
studies revealed a prerequisite of uPAR expression in podocytes, 
but not in endothelial cells, for the development of LPS-mediated 
proteinuria. Blockade of αvβ3 integrin reduced podocyte motility 
in vitro and lowered proteinuria in mice. These ﬁndings show a 
physiological role for uPAR signaling in the regulation of kidney 
permeability. Nonetheless, the role of uPAR in other glomerular 
cell types, as well as the potential interactions podocyte uPAR may 
have with other integrins and nonintegrins, needs to be studied 
further. (Nat Med 2008; 14: 55–63; doi:10.1038/nm1696)
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TGF-β1 inhibits P-cadherin expression in podocytes.
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Induction of uPAR protein in podocytes in mouse models of 
proteinuria, as revealed by immunocytochemistry. NZB/W F1,  
New Zealand black and white F1 mice; Con, control glomeruli; Synpo, 
podocyte marker synaptopodin.
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Entosis and cell death by invasion is 
a nonapoptotic process
In multicellular organisms, cell proliferation and death are care-
fully coordinated to control the number and organization of 
cells in tissues and organs. Attachment to extracellular matrix 
is required for epithelial cells to suppress an apoptotic cell death 
program termed anoikis. Overholtzer et al. recently described a 
nonapoptotic cell death program in matrix-detached cells (that 
is, cells in suspension) that is initiated by a previously unrecog-
nized and unusual process involving the invasion of one cell into 
another (Figure 1), leading to a transient state in which a live cell 
is contained within a neighboring host cell. The authors termed 
this cell internalization process entosis, after the Greek word entos, 
which means ‘inside, into, or within.’ While entosis and apoptosis 
both can result in the internalization of one cell inside another 
and death of the internalized cell, the mechanisms responsible for 
cell internalization are highly distinguishable. Unlike the phago-
cytic ingestion of apoptotic cells, cell internalization and death 
by entosis is not associated with caspase activation nor driven by 
phosphatidylserine exposure. Rather, it is dependent on adherens 
junctions and is driven by Rho and Rho-associated coil-forming 
kinase activity in internalizing cells, which is consistent with a cell 
invasion process rather than an engulfment process. Surprisingly, 
live internalized cells can also be released or undergo cell division 
(Figure 2), which highlights a further distinguishing aspect from 
cell engulfment in apoptosis; unlike dying cells that are cleared 
by phagocytosis, cells internalized by entosis are alive. Entosis 
likely explains the commonly observed ‘cell-in-cell’ cytological 
feature in human cancers and may represent an intrinsic tumor 
suppression mechanism for cells that are detached from extra-
cellular matrix. The potential role of entosis in homeostatic and 
development processes remains to be explored. (Cell 2007; 131: 
966–979; doi:10.1016/j.cell.2007.10.040)
Juan Oliver
Factor I required to develop MPGN2 
in factor H deficiency
Membranoproliferative glomerulonephritis type II (MPGN2, 
also termed dense deposit disease) is characterized by the pres-
ence of intramembranous electron-dense material together 
with staining for C3, C5, and C9 along the glomerular base-
ment membrane (GBM) in the absence of immunoglobulin. 
Uncontrolled activation of the alternative pathway of comple-
ment activation is an important feature of MPGN2. Spontaneous 
activation of C3 through the alternative pathway is regulated by 
two plasma proteins, factor H and factor I. Deﬁciency of either 
of these regulators results in uncontrolled C3 activation. While 
uncontrolled alternative pathway regulation and MPGN2 may 
occur in individuals with normal factor H and factor I activities, 
complete factor H deﬁciency results in spontaneous MPGN2. 
Despite the overwhelming evidence linking alternative path-
way dysregulation and MPGN2, it is striking that MPGN2 has 
never been reported in individuals with factor I deﬁciency. 
To determine why individuals with uncontrolled C3 activa-
tion due to factor I deﬁciency do not develop MPGN2, Rose 
et al. generated factor I-deﬁcient (Cﬁ–/–) mice. These animals 
displayed uncontrolled alternative pathway activation as evi-
denced by reduced C3, factor B, and factor H levels but did not 
develop C3 deposition along the GBM or MPGN2. Hence, the 
renal phenotype of these mice diﬀered signiﬁcantly from the 
one reported previously in factor H-deﬁcient (Cfh–/–) mice. 
Remarkably, GBM C3 deposition did not occur, even in mice 
with combined deﬁciency of factors H and I (Cfh–/–Cﬁ–/–), 
despite the presence of uncontrolled alternative pathway acti-
vation. Analysis of plasma C3 activation fragments demon-
strated that, in the absence of factor I, C3 circulated in the form 
of C3b with no evidence of formation of C3 metabolites. In 
contrast, in Cfh–/– mice, C3b cleavage fragments were detect-
able in plasma. Reconstitution of factor I in Cfh–/–Cﬁ–/– mice 
precipitated GBM C3 deposition together with the concomi-
tant appearance of C3b cleavage fragments in circulation. Renal 
transplant experiments conﬁrmed that glomerular C3 deposi-
tion derives from the circulation in Cfh–/– animals. These elegant 
experiments demonstrate that factor I-mediated generation of 
activated C3 fragments in the circulation is critical for the devel-
opment of MPGN2 associated with factor H deﬁciency. (J Clin 
Invest 2008; 118: 608–618; doi:10.1172/JCI32525)
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Figure 2 | Internalized cells can be released and can divide.  
(a) Internalized cell is released. White arrow marks previously internalized 
cell; black arrow marks outer cell. (b) Internalized cell divides.
Figure 1 | Suspended cells internalize into their neighbors.
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